Microglial activation in young adults with autism spectrum disorder
- PMID: 23404112
- DOI: 10.1001/jamapsychiatry.2013.272
Microglial activation in young adults with autism spectrum disorder
Abstract
Context: A growing body of evidence suggests that aberrant immunologic systems underlie the pathophysiologic characteristics of autism spectrum disorder (ASD). However, to our knowledge, no information is available on the patterns of distribution of microglial activation in the brain in ASD.
Objectives: To identify brain regions associated with excessively activated microglia in the whole brain, and to examine similarities in the pattern of distribution of activated microglia in subjects with ASD and control subjects.
Design: Case-control study using positron emission tomography and a radiotracer for microglia--[11C](R)-(1-[2-chrorophynyl]-N-methyl-N-[1-methylpropyl]-3 isoquinoline carboxamide) ([11C](R)-PK11195).
Setting: Subjects recruited from the community.
Participants: Twenty men with ASD (age range, 18-31 years; mean [SD] IQ, 95.9 [16.7]) and 20 age- and IQ-matched healthy men as controls. Diagnosis of ASD was made in accordance with the Autism Diagnostic Observation Schedule and the Autism Diagnostic Interview-Revised.
Main outcome measures: Regional brain [11C](R)-PK11195 binding potential as a representative measure of microglial activation.
Results: The [11C](R)-PK11195 binding potential values were significantly higher in multiple brain regions in young adults with ASD compared with those of controls (P < .05, corrected). Brain regions with increased binding potentials included the cerebellum, midbrain, pons, fusiform gyri, and the anterior cingulate and orbitofrontal cortices. The most prominent increase was observed in the cerebellum. The pattern of distribution of [11C](R)-PK11195 binding potential values in these brain regions of ASD and control subjects was similar, whereas the magnitude of the [11C](R)-PK11195 binding potential in the ASD group was greater than that of controls in all regions.
Conclusions: Our results indicate excessive microglial activation in multiple brain regions in young adult subjects with ASD. The similar distribution pattern of regional microglial activity in the ASD and control groups may indicate augmented but not altered microglial activation in the brain in the subjects with ASD.
Comment in
-
Dramatic increase in autism prevalence parallels explosion of research into its biology and causes.JAMA Psychiatry. 2013 Jan;70(1):9-10. doi: 10.1001/jamapsychiatry.2013.488. JAMA Psychiatry. 2013. PMID: 23184000 No abstract available.
Similar articles
-
Reduced acetylcholinesterase activity in the fusiform gyrus in adults with autism spectrum disorders.Arch Gen Psychiatry. 2011 Mar;68(3):306-13. doi: 10.1001/archgenpsychiatry.2011.4. Arch Gen Psychiatry. 2011. PMID: 21383265
-
Microglial activation in perinatal rabbit brain induced by intrauterine inflammation: detection with 11C-(R)-PK11195 and small-animal PET.J Nucl Med. 2007 Jun;48(6):946-54. doi: 10.2967/jnumed.106.038539. Epub 2007 May 15. J Nucl Med. 2007. PMID: 17504871
-
PET imaging of putative microglial activation in individuals at ultra-high risk for psychosis, recently diagnosed and chronically ill with schizophrenia.Transl Psychiatry. 2017 Aug 29;7(8):e1225. doi: 10.1038/tp.2017.193. Transl Psychiatry. 2017. PMID: 28850113 Free PMC article.
-
Positron emission tomography imaging of neuroinflammation.Neurotherapeutics. 2007 Jul;4(3):443-52. doi: 10.1016/j.nurt.2007.04.006. Neurotherapeutics. 2007. PMID: 17599710 Free PMC article. Review.
-
Neuroinflammation in the living brain of Parkinson's disease.Parkinsonism Relat Disord. 2009 Dec;15 Suppl 3:S200-4. doi: 10.1016/S1353-8020(09)70814-4. Parkinsonism Relat Disord. 2009. PMID: 20082990 Review.
Cited by
-
Bridging the Gap Between Physical Health and Autism Spectrum Disorder.Neuropsychiatr Dis Treat. 2020 Jun 30;16:1605-1618. doi: 10.2147/NDT.S251394. eCollection 2020. Neuropsychiatr Dis Treat. 2020. PMID: 32636630 Free PMC article. Review.
-
Antigenic Targets of Patient and Maternal Autoantibodies in Autism Spectrum Disorder.Front Immunol. 2019 Jul 19;10:1474. doi: 10.3389/fimmu.2019.01474. eCollection 2019. Front Immunol. 2019. PMID: 31379804 Free PMC article. Review.
-
The Role of Gut Dysbiosis in the Pathophysiology of Neuropsychiatric Disorders.Cells. 2022 Dec 23;12(1):54. doi: 10.3390/cells12010054. Cells. 2022. PMID: 36611848 Free PMC article. Review.
-
Current progress and challenges in the search for autism biomarkers.Dis Markers. 2013;35(1):55-65. doi: 10.1155/2013/476276. Epub 2013 Jul 21. Dis Markers. 2013. PMID: 24167349 Free PMC article. Review.
-
Higher Levels of Galectin-1 and Galectin-3 in Young Subjects with Autism Spectrum Disorder Compared to Unaffected Siblings and Healthy Controls.Clin Psychopharmacol Neurosci. 2023 Nov 30;21(4):749-757. doi: 10.9758/cpn.23.1052. Epub 2023 May 30. Clin Psychopharmacol Neurosci. 2023. PMID: 37859448 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources